Potassium Carbonate → 6'-(5-Chloropyridin-3-yl)-4-(difluoromethyl)-5''-methyl-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine

HRID 1965151

반응식

HRID 1965151 반응식
Br[C:2]1[CH:24]=[C:23]2[C:5]([CH2:6][C:7]3([C:16]42[N:20]=[C:19]([NH2:21])[C:18]([CH3:22])=[N:17]4)[CH2:12][CH2:11][CH:10]([CH:13]([F:15])[F:14])[CH2:9][CH2:8]3)=[CH:4][CH:3]=1.[Cl:25][C:26]1[CH:27]=[C:28](B(O)O)[CH:29]=[N:30][CH:31]=1.CC([PH+](C(C)(C)C)CCCS([O-])(=O)=O)(C)C.C([O-])([O-])=O.[K+].[K+]>[Na+].[Na+].Cl[Pd+2](Cl)(Cl)Cl>[Cl:25][C:26]1[CH:27]=[C:28]([C:2]2[CH:24]=[C:23]3[C:5]([CH2:6][C:7]4([C:16]53[N:20]=[C:19]([NH2:21])[C:18]([CH3:22])=[N:17]5)[CH2:8][CH2:9][CH:10]([CH:13]([F:14])[F:15])[CH2:11][CH2:12]4)=[CH:4][CH:3]=2)[CH:29]=[N:30][CH:31]=1

참가 물질

6

반응물 4

HCID 11430Potassium CarbonateHCID 201118775-Chloropyridine-3-boronic acidHCID 249491873-(Di-tert-butylphosphonium)propane sulfonateHCID 679795776'-Bromo-4-(difluoromethyl)-5''-methyl-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine

생성물 1

HCID 679793846'-(5-Chloropyridin-3-yl)-4-(difluoromethyl)-5''-methyl-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine수율 11.2%

시약·촉매·용매 1

HCID 178479786HCID 178479786, 화합물촉매

반응 조건

온도
100 °C

실험 절차

6′-Bromo-4-(difluoromethyl)-5″-methyl-3′H-dispiro[cyclohexane-1,2′-indene-1′,2″-imidazol]-4″-amine (Example 128, 0.1 g, 0.25 mmol), 5-chloropyridin-3-yl boronic acid (0.048 g, 0.30 mmol), 3-(di-tert-butylphosphonium)propane sulfonate (6.77 mg, 0.03 mmol), sodium tetrachloro-palladate(II) (3.71 mg, 0.01 mmol), 2-Me THF (2 mL) and aq. K2CO3 (2.0 M, 0.379 mL, 0.76 mmol) were added to a microwave vial. The vial was sealed and evacuated and refilled with Ar (g) and then heated in the microwave reactor for 30 min at 100° C. The same amount of Pd-catalyst, ligand and boronic ester were added and the vial was sealed and evacuated and refilled with Ar (g). The vial was heated in the microwave reactor for 30 min at 100° C. EtOAc and water were added and the organic phase was extracted, dried through a phase separator and evaporated to dryness. The crude product was purified using preparative chromatography to give the title compound (12 mg, 11% yield): 1H NMR (500 MHz, CD3CN) δ ppm 1.24-1.41 (m, 4 H), 1.45-1.54 (m, 3 H), 1.71-1.86 (m, 1 H), 2.00 (dt, 1 H), 2.24 (s, 3 H), 2.98 (d, 1 H), 3.07 (d, 1 H), 5.32 (br. s., 2 H), 5.64 (d, 1 H), 6.86 (d, 1 H), 7.38 (d, 1 H), 7.50 (dd, 1 H), 7.93 (t, 1 H), 8.49 (d, 1 H), 8.65 (d, 1 H); MS (MM−ES+APCI)+ m/z 429 [M+H]+.

후처리

  1. customThe vial was sealed
  2. customevacuated
  3. additionrefilled with Ar (g)
  4. additionThe same amount of Pd-catalyst, ligand and boronic ester were added
  5. customthe vial was sealed
  6. customevacuated
  7. additionrefilled with Ar (g)
  8. temperatureThe vial was heated in the microwave reactor for 30 min at 100° C
  9. additionEtOAc and water were added
  10. extractionthe organic phase was extracted
  11. customdried through a phase separator
  12. customevaporated to dryness
  13. customThe crude product was purified

출처 및 근거

ORD 기록
ord-40ff2a9e26b446138c7fc2c12917a698
출처 데이터셋
uspto-grants-2013_04
특허 번호
US08415483B2

연결된 노트

불러오는 중…